Private Equity
Jupiter, Florida-based X-Vax Technology Inc, a herpes vaccines developer, has raised $56 million in funding. The investors included Johnson & Johnson Innovation – JJDC, Inc., Adjuvant Capital, Serum Institute of India, Alexandria Venture Investments and FF DSF VI.</strong
1 min read · 23 July 2019
Flare Capital Partners has closed its second fund at $255 million. The Boston-based venture firm invests in healthcare technology.
3 min read · 23 July 2019
1 min read · 23 July 2019
1 min read · 23 July 2019
1 min read · 19 July 2019
2 min read · 19 July 2019
Forendo Pharma, a Finnish drug developer focused on women's health, has secured 5 million euros in funding. The investor was Sunstone Life Science Ventures. In addition to the funding, Claus Andersson, a general partner from Sunstone, joins Forendo Pharma's board of directors.
1 min read · 19 July 2019
Secfi, a financing provider for option exercise and holders of private company stock, has raised $6 million in Series A funding. Rucker Park Capital led the round.
1 min read · 19 July 2019
El Segundo, California-based Radiology Partners, a radiology practice in the U.S., has raised about $700 million in funding. The backer was Starr Investment Holdings.
1 min read · 19 July 2019
Medicixi, a European life sciences investment firm, has closed its third fund at 400 million euros. The investors in Medicixi III include Novartis and Johnson & Johnson Innovation – JJDC, Inc. The fund will invest in early and late-stage biopharma companies.
3 min read · 19 July 2019
